Currently, the share price for Cipla Ltd. is delayed. Login to view live prices.
Cipla Ltd.
- Prev. Close1,465.50
- Upper Circuit1,635.15
- Lower Circuit1,337.85
Analyst Sentiment For Cipla Ltd.
Returns
Cipla Ltd.'s Info & Management
Cipla Limited is an Indian-origin multi-national company in the pharmaceutical sector. The company was established in 1935 and is headquartered in Mumbai, India.
Business Segment
The company operates through two segments:
- Pharmaceuticals: is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API)
- New ventures: includes the operations of the company, consumer healthcare, Biosimilars and speciality businesses
- Product Portfolio: spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS)
Geographical Presence
Its operations span across India, South Africa, and North America. The company has approximately 47 manufacturing sites around the world and produces 50+ dosage forms and 1,500+ generic products to cater to over 85 markets.
Check Cipla share price for a comprehensive analysis with integrated tools for fundamental and technical analysis. Also, access the company profile, news, and events on Share.Market. Find detailed analysis of Cipla stock price to kickstart your investment journey now.
- Global Head(Quality)Vijayasarathi R.
- Executive Director,Managing Director,Chief Executive OfficerUmang Vohra
- Global Head(Supply Chain.)Mr Sai Mungara
- Chief Information OfficerMs Sneha Hiranandani
- Chief Executive Officer(North America)Mr Marc Falkin
- Chief Executive Officer(South Africa),Regional Head(Africa,Access)Mr Paul Miller